Solensky Gerald JR 4
4 · Zomedica Pharmaceuticals Corp. · Filed Dec 19, 2017
Insider Transaction Report
Form 4
Solensky Gerald JR
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Shares, without par value
2017-12-19$1.20/sh+750,000$900,000→ 37,951,100 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-19−750,000→ 200,000 totalExercise: $1.20From: 2016-12-21Exp: 2018-12-21→ Common Shares, without par value (750,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.